pentylenetetrazole has been researched along with Pervasive Child Development Disorders in 2 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
Excerpt | Relevance | Reference |
---|---|---|
" Susceptibility to absence seizures was examined by analysing the frequency and duration of spike-and-wave discharge (SWD) events and accompanying motor seizure activity induced by subcutaneous administration of low dosage (20 or 30mg/kg) PTZ." | 1.42 | Reduced susceptibility to induced seizures in the Neuroligin-3(R451C) mouse model of autism. ( Anderson, P; Argyropoulos, A; Hannan, AJ; Hill-Yardin, EL; Hosie, S; O'Brien, TJ; Rind, G, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, JA | 1 |
Clesse, D | 1 |
Spiegelhalter, C | 1 |
Schwab, Y | 1 |
Le Merrer, J | 1 |
Kieffer, BL | 1 |
Hill-Yardin, EL | 1 |
Argyropoulos, A | 1 |
Hosie, S | 1 |
Rind, G | 1 |
Anderson, P | 1 |
Hannan, AJ | 1 |
O'Brien, TJ | 1 |
2 other studies available for pentylenetetrazole and Pervasive Child Development Disorders
Article | Year |
---|---|
Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.
Topics: Aggression; Anilides; Animals; Anxiety; Behavior, Animal; Brain; Child Development Disorders, Pervas | 2014 |
Reduced susceptibility to induced seizures in the Neuroligin-3(R451C) mouse model of autism.
Topics: Animals; Cell Adhesion Molecules, Neuronal; Child Development Disorders, Pervasive; Dose-Response Re | 2015 |